Medtronic EnPulse To Energize Pacemaker Growth Of Up To 10% In Q4
This article was originally published in The Gray Sheet
Executive Summary
The U.S. launch of Medtronic's Atrial Capture Management feature on its EnPulse pacemaker will help pacing sector growth "rise to the high single digits, and possibly 10% range," according to the firm
You may also be interested in...
CMS Welcomes SCD-HeFT Data, Awaits COMPANION Study For ICD Review
CMS plans to integrate Guidant's COMPANION study findings with recently released data from the SCD-HeFT trial to make a decision on whether to redefine the patient population eligible for ICD coverage
Guardian Approval Should Give Medtronic Sizable Lead In CGMS Market
FDA approval of Medtronic's Guardian continuous glucose monitoring system gives the firm a headstart on primary competitor TheraSense's FreeStyle Navigator CGMS
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.